1. Immunotherapy in esophageal cancer-An update
   Bhavesh Parekh et al, 2019, International Journal of Molecular and Immuno Oncology CrossRef
2. A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies
   Dedong Cao et al, 2018, OncoImmunology CrossRef